Clincosm LogoSign in Get a demo

metastatic renal cell carcinoma

Showing NaN - NaN of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +12 more
  • Tucson, Arizona
  • +60 more
Jan 11, 2023

Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • Nephrectomy
  • +4 more
  • Birmingham, Alabama
  • +414 more
Dec 30, 2022

Database to prospectivelY aSSEss Changing TherapY Landscape in

Recruiting
  • Metastatic Renal Cell Carcinoma
    • Iowa City, Iowa
    • +7 more
    Oct 13, 2022

    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Stage III Renal

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • +4 more
    • Birmingham, Alabama
    • +255 more
    Aug 24, 2022

    Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

    Completed
    • Metastatic Renal Cell Carcinoma
    • +4 more
    • HyperAcute®-Renal (HAR) Immunotherapy
    • Iowa City, Iowa
    • +2 more
    Apr 4, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Metastatic Renal Cell Carcinoma
    • bempegaldesleukin
    • +3 more
    • Anchorage, Alaska
    • +108 more
    Mar 31, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Mar 14, 2022

    Advanced Solid Tumors, Metastatic Renal Cell Carcinoma Trial in United States (Part 1: M8891)

    Terminated
    Has Results
    • Advanced Solid Tumors
    • Metastatic Renal Cell Carcinoma
    • Part 1: M8891
    • New Haven, Connecticut
    • +6 more
    Dec 21, 2021

    Metastatic Renal Cell Carcinoma Trial in Canada, United States (AGS-16C3F, Axitinib)

    Completed
    Has Results
    • Metastatic Renal Cell Carcinoma
    • Tucson, Arizona
    • +25 more
    Nov 9, 2021

    Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (CB-839, Cabozantinib, Placebo)

    Completed
    • Advanced Renal Cell Carcinoma
    • Metastatic Renal Cell Carcinoma
    • Birmingham, Alabama
    • +132 more
    Aug 18, 2021

    Metastatic Renal Cell Carcinoma Trial in Korea, Republic of, United States (CRLX101, Bevacizumab, Standard of Care (Investigator

    Completed
    • Metastatic Renal Cell Carcinoma
    • La Jolla, California
    • +42 more
    May 26, 2020

    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,

    Terminated
    • Advanced Renal Cell Carcinoma
    • +2 more
    • Standard Treatment
    • AGS-003
    • Scottsdale, Arizona
    • +124 more
    Jun 13, 2018

    Metastatic Renal Cell Carcinoma Trial in Worldwide (Sunitinib, GM-CSF, Cyclophosphamide)

    Completed
    • Metastatic Renal Cell Carcinoma
    • Little Rock, Arkansas
    • +105 more
    Oct 4, 2017

    Metastatic Renal Cell Carcinoma Trial in Peru, United States (VEGF Trap)

    Completed
    Has Results
    • Metastatic Renal Cell Carcinoma
    • VEGF Trap
    • Aurora, Colorado
    • +204 more
    May 30, 2017

    Metastatic Renal Cell Carcinoma Trial in Worldwide (Dovitinib, Sorafenib)

    Completed
    Has Results
    • Metastatic Renal Cell Carcinoma
    • Fayetteville, Arkansas
    • +198 more
    Nov 5, 2015

    Metastatic Renal Cell Carcinoma Trial in Worldwide (RAD001, Placebo)

    Completed
    Has Results
    • Metastatic Renal Cell Carcinoma
    • Fayetteville, Arkansas
    • +92 more
    Dec 7, 2012

    Metastatic Renal Cell Carcinoma Trial in Indianapolis, Baltimore, Madison (Panzem® NCD, Sunitinib Malate)

    Completed
    • Metastatic Renal Cell Carcinoma
    • Panzem® NCD
    • Sunitinib Malate
    • Indianapolis, Indiana
    • +2 more
    Aug 3, 2011